{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:22:41Z","timestamp":1761517361873,"version":"build-2065373602"},"reference-count":6,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[1999,9,1]],"date-time":"1999-09-01T00:00:00Z","timestamp":936144000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[1999,9,1]],"date-time":"1999-09-01T00:00:00Z","timestamp":936144000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[1999,9]]},"DOI":"10.4158\/ep.5.5.257","type":"journal-article","created":{"date-parts":[[2013,4,5]],"date-time":"2013-04-05T23:34:55Z","timestamp":1365204895000},"page":"257-260","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Thyrotropin-Secreting Pituitary Adenoma Responsive To Bromocriptine Therapy"],"prefix":"10.1016","volume":"5","author":[{"given":"Pauline","family":"Camacho","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theodore","family":"Mazzone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.4158\/EP.5.5.257_bb0005","first-page":"610","article-title":"Thyrotropin-secreting pituitary tumors","volume":"17","author":"Beck-Peccoz","year":"1996","journal-title":"Endocr Rev."},{"key":"10.4158\/EP.5.5.257_bb0010","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1210\/jcem-71-1-19","article-title":"Sex hormone-binding globulin measurement in patients with inappropriate secretion of thyrotropin (1ST): evidence against selective pituitary thyroid hormone resistance in nonneoplastic 1ST","volume":"71","author":"Beck-Peccoz","year":"1990","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP.5.5.257_bb0015","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1210\/edrv-10-2-113","article-title":"Thyrotoxicosis due to ingestion of excess thyroid hormone","volume":"10","author":"Cohen","year":"1989","journal-title":"Endocr Rev."},{"key":"10.4158\/EP.5.5.257_bb0020","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/0002-9343(83)91086-0","article-title":"Hyperthyroidism and acromegaly due to a thyrotropin- and growth hormone-secreting pituitary tumor: lack of hormonal response to bromocriptine","volume":"74","author":"Carlson","year":"1983","journal-title":"Am J Med."},{"key":"10.4158\/EP.5.5.257_bb0025","doi-asserted-by":"crossref","first-page":"281","DOI":"10.7326\/0003-4819-96-3-281","article-title":"Size reduction of extrasellar pituitary tumors during bromocriptine treatment","volume":"96","author":"Wollesen","year":"1982","journal-title":"Ann Intern Med."},{"key":"10.4158\/EP.5.5.257_bb0030","first-page":"291","article-title":"Large somatostatin-insensitive thyrotrophin-secreting pituitary tumour responsive to D-thyroxine and dopamine agonists","volume":"129","author":"Karlsson","year":"1993","journal-title":"Acta Endocrinol (Copenh)."}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20402903?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20402903?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/aace.metapress.com\/index\/04BK14J8EH7FEKLF.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:18:15Z","timestamp":1761517095000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20402903"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,9]]},"references-count":6,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1999,9]]}},"alternative-id":["S1530891X20402903"],"URL":"https:\/\/doi.org\/10.4158\/ep.5.5.257","relation":{},"ISSN":["1530-891X"],"issn-type":[{"type":"print","value":"1530-891X"}],"subject":[],"published":{"date-parts":[[1999,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thyrotropin-Secreting Pituitary Adenoma Responsive To Bromocriptine Therapy","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP.5.5.257","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 1999 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}